Reinventing Children’s Health through Game-Changing Pediatric Research and Innovation – 2023 Buffet Luncheon (Kiosk-Style) Event
Reinventing Children’s Health through Game-Changing Pediatric Research and Innovation
Tuesday, May 16, 2023
Fairmont Château Laurier
12:00 pm – 1:30 pm: Kiosk Style – Reinventing Children’s Health through Game-Changing Pediatric Research and Innovation
Hosted by Research Canada. Welcome by Ms. Deborah Gordon-El-Bihbety, Research Canada’s President and CEO with Special Remarks from Dr. Rose Goldstein, Research Canada’s Chair.
Children are NOT “small adults.” They are different from their parents and other adults and require different diagnostics, therapies and treatments. Pediatric research in Canada has resulted in improvements in child health and outcomes of health care. Moreover, improving children’s health and wellbeing has far reaching implications for adult health and reducing the growing burden of noncommunicable, chronic adult diseases.
For this event, researchers and innovators will present under the following sub-themes:
- The Long-term Impact of COVID-19 in Children and Youth
- The Mental Health of Early- and School-Aged Children
- The Challenges and Benefits of Pediatric Clinical Trials
- Introduction of Precision Medicine to Improve Outcomes of Treatment for Children in Canada
- Equity and Child Health
Theme 1: Long-term Impact of COVID-19 in Children and Youth
Caroline Quach-Thanh, OQ MD MSc
Professor, Département de microbiologie et immunologie, Université de Montréal, Faculté de médecine
Dr. Quach-Thanh is a clinician-researcher at the CHU Sainte-Justine of the Université de Montréal. She holds the Canada Research Chair (Tier 1) in Infection Prevention: From Hospital to Community. Her research is primarily on the most medically vulnerable populations. Her expertise in pediatric infectious diseases has allowed her to develop a network that brings together the 16 Canadian pediatric hospitals (POPCORN) which allows her to recruit and follow a child through her care trajectory in order to understand the burden and consequences of COVID-19.
Piush Mandhane, MD, PhD, FRCPC
Professor, Department of Pediatrics, Division of Pediatric Respirology, Pulmonary and Asthma, University of Alberta
Dr. Piush Mandhane is a Paediatric Respirologist Clinician Scientist at the University of Alberta and Stollery Children’s Hospital. His work through the CHILD birth cohort centered on childhood sleep and neurodevelopment. Through the pandemic, Dr. Mandhane examined childhood immunity to SARS-CoV-2 infection. More recently, he has focused on paediatric long COVID as a principal investigator of the recently-funded long COVID web and co-chairing a Alberta Health Services committee developing care pathways for paediatric long COVID.
Theme 2: The Mental Health of Early- and School-Aged Children
Leena Augimeri, PhD
Director, Program Scaling, Strategic Partnerships and SNAP, Child Development Institute
Leena is the Director, Program Scaling, Strategic Partnerships & SNAP at the Child Development Institute, and Adjunct Professor, University of Toronto. For 38 years, Leena has focused on research, development, dissemination and implementation of SNAP, an evidence-based children’s mental health (MH) program, and comprehensive crime prevention framework for children/youth with serious disruptive behaviour problems (referral protocols, risk/need assessment, gender-sensitive programs). Dr. Augimeri has authored numerous publications, conducted hundreds of presentations, and received several prestigious awards (e.g., National Recipient – CAMH Difference Makers of 150 Leading Canadians for MH, Child Welfare League of Canada’s Outstanding Achievement Research Award, Prime Minister’s Regional Social Innovation Award and Elizabeth Manson Award for exemplary contributions to the promotion of children’s MH).
Senior Manager, Research and Development
Margaret is the Senior Manager, Research and Development at the Child Development Institute (CDI). Margaret works closely with her colleague, Dr. Leena Augimeri on program development, research and implementation activities for SNAP, an evidence-based model for children with serious disruptive behaviours and their families. She is a co-principal contributor to CDI’s newest SNAP model, SNAP Youth Justice. She heads the development of the SNAP Fidelity Frameworks and data system (SNAPiT) designed to support implementations across Canada. Margaret is co-author of the EARL (Early Assessment Risk List) gender-sensitive risk assessment tool for children, under the age of 12, at risk for future delinquency and violence. She has authored several SNAP publications including the randomized controlled study on the SNAP Girls intervention.
Lise Milne, PhD
Associate Professor in Social Work and Chair, Child Trauma Research Centre, University of Regina
Dr. Milne is the Child Trauma Research Centre Chair in Intervention and Prevention Approaches Supporting Child and Youth Health and Well-Being, and Associate Professor, University of Regina Faculty of Social Work. Dr. Milne’s area of research is on better understanding and reducing the impact of early childhood trauma, including neurobiological impacts, informed by the Neurosequential Model of Therapeutics. Her current research focuses on implementing and evaluating a program for expectant parents who were exposed to childhood adversity, to interrupt the inter-generational cycle of trauma.
Vivian Lee, PhD
Assistant Professor, Kids Brain Health Network, Carleton University
Dr. Vivian Lee is an Assistant Professor in the Department of Psychology at Carleton University. She is a developmental psychologist interested in ways we can promote positive emotion regulation and healthy mental health in autistic children and their families. With support from the Kids Brain Health Network, she is evaluating the delivery of an adapted socio-emotional intervention called the Secret Agent Society Small Group program in publicly funded community-based services providers.
Theme 3: The Challenges and Benefits of Pediatric Clinical Trials
Doug Mahoney, PhD
Assistant Professor, Microbiology, Immunology and Infectious Disease, BioCanRx, University of Calgary
Dr. Mahoney is a translational scientist at the Charbonneau Cancer Institute and Alberta Children’s Hospital Research Institute within the Cumming School of Medicine at the University of Calgary. His research is focused on engineering “designer cells and viruses” to treat various forms of cancer in children, adolescents, and adults. His work spans preclinical research to small, innovative clinical trials in human patients.
Matthew Bromwich, MD, FRCSC
Department of Pediatric Otolaryngology, CHEO, Director TECHi, CHEO, Investigator, CHEO Research Institute, Associate Professor of Otolaryngology, University of Ottawa
Dr. Matthew Bromwich is a leading Otolaryngologist and Associate Professor at the University of Ottawa. He is the director of TECHi at the CHEO-RI, whose main objective is advancing healthcare innovation by partnering with early stage companies to elevate the healthcare industry. His own ground-breaking work includes the creation of the “Shoebox Audiometer,” a portable, user-friendly hearing assessment device that revolutionizes access to care. Dr. Bromwich’s ongoing research and innovations continue to positively impact patients worldwide.
Theme 4: Introduction of Precision Medicine to Improve Outcomes of Treatment for Children in Canada
Victoria Chester, PhD
Co-Director, Andrew and Marjorie McCain Human Performance Laboratory
Professor, University of New Brunswick, Fredericton
Dr. Chester is Co-Director of the Andrew and Marjorie McCain Human Performance Laboratory at the University of New Brunswick. Dr. Chester is a mechanical engineer/kinesiologist working with clinicians to develop novel and intelligent healthcare tools to detect, diagnose and treat gait impairments in children with autism. Personalized medicine using AI techniques provides an innovative approach to diagnosis and establishing optimal treatment, leading to improved function, quality of life, and reduced chronic conditions in children.
Christine Bear, PhD
Senior Scientist, Molecular Medicine, SickKids
Christine Bear is a Senior Scientist at SickKids Hospital and Professor at the University of Toronto. She co-directs the Cystic Fibrosis research program that makes mini-lungs from patient stem cells and uses these mini-lungs to find out which drugs are best for each person. With continuing support, Dr. Bear will use the program to optimize the efficacy and safety of tools that aim to prevent CF in children by removing CF mutations through genome editing.
Vijay Ramaswamy, MD, PhD, FRCPC
Canada Research Chair in Pediatric Neuro-Oncology, Scientist and Staff Neuro-Oncologist, Hospital for Sick Children, Associate Professor, University of Toronto
Dr. Vijay Ramaswamy is currently appointed as both a Scientist and Pediatric Neuro-Oncologist at the Hospital for Sick Children. He is a cancer biologist with an interest in the genomics of pediatric brain tumours, specifically defining high-risk subsets and investigating novel therapeutic strategies to overcome treatment resistance. With ongoing support from the Canadian Institutes for Health Research, Canadian Cancer Society and Brain Canada, he is using functional genomics to advance our understanding of treatment failure.
Theme 5: Equity and Child Health
- Lisa Christian, OD, FCOVD, FAAO
- Quynh Doan, MDCM, FRCPC, MHSc, PhD
- Stacey Marjerrison, MD, MSc, FRCPC
Lisa Christian, OD, FCOVD, FAAO
Associate Clinical Professor and Associate Director of Clinical Education, The Canadian Association of Optometrists (CAO), University of Waterloo
Dr. Lisa Christian is an Associate Clinical Professor at the University of Waterloo, School of Optometry and Vision Science. She is an Optometrist with a residency in pediatrics. Her research focuses on the best methods to deliver and manage eye diseases for children with socioeconomic barriers, autism, and intellectual disabilities. Through this research, Dr. Christian aims inform public health policy by developing a model of vision care that is accessible and equitable for all children.
Quynh Doan, MDCM, FRCPC, MHSc, PhD
Investigator and Pediatric Emergency Physician, BC Children’s Hospital, Provincial Health Services Authority (PHSA) and Associate Professor, Pediatric Emergency Medicine, Department of Pediatrics, University of British Columbia
Dr.Quynh Doan is a pediatric emergency physician and health services researcher at the University of British Columbia. She is also the Interim Senior Executive Director and Director of Clinical Research at the BC Children’s Hospital Research Institute, where she fosters thought diversity and inclusive experiences. Her research and institutional practices aim to optimize inclusivity and minimize participants exclusion based on language proficiency, for generalizable knowledge creation, enabling equitable and evidence based child health.
Stacey Marjerrison, MD, MSc, FRCPC
Pediatric Oncologist and Medical Director of Pediatric Oncology Late Effects Program, McMaster University
Dr. Stacey Marjerrison is a pediatric oncologist and Medical Director of the AfterCare Program at McMaster Children’s Hospital. She is an Associate Professor at McMaster University where she holds the Ronald Barr Professorship in Pediatric Oncology. Within the Canadian Pediatric Cancer Consortium, Dr. Marjerrison leads the Social justice, Indigenization and Inclusion working group. Her areas of research interest are cancer survivorship, supportive care, and the interaction between socio-demographic determinants of health and childhood chronic illness.
THANK YOU TO OUR SPONSORS
Innovative Medicines Canada is the national association representing the voice of Canada’s innovative pharmaceutical industry. The association advocates for policies that enable the discovery, development, and delivery of innovative medicines and vaccines to improve the lives of all Canadians and supports the members’ commitment to being a valued partner in the Canadian healthcare system.